Context Therapeutics Q1 2026 Earnings Narrowing Losses with EPS Beat of 2481 MPC Q1 2026 Earnings EPS Surges Past Estimates by 1186 IRS Q1 2026 Earnings Negative EPS Amid Argentine Macro Headwinds Stock Edges Higher REGCO Q1 2026 Earnings Preferred Stock Delivers Solid EPS Beat Amid Market Headwinds C3is Inc CISS Q3 2025 Earnings Reported Loss Amid Market Headwinds CLB Q1 2026 Earnings EPS Misses Estimates by 4516 Amid Operational Headwinds ES Q1 2026 Earnings EPS Misses Estimates Amid Utility Operational Pressures